Global Drugs Produced by Fermentation Engineering Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08242874

Publication Date:

August 5, 2024

Pages:

103

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Fermentation is a process used for cultivating micro-organisms or other organic material into important drugs such as antibiotics, therapeutic proteins, enzymes and insulin. It is typically carried out in temperature-controlled tanks (fermenter) which require addition of nutrients at the correct concentration to maximize productivity of the organism of interest.
The global Drugs Produced by Fermentation Engineering market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淒rugs Produced by Fermentation Engineering Industry Forecast鈥� looks at past sales and reviews total world Drugs Produced by Fermentation Engineering sales in 2022, providing a comprehensive analysis by region and market sector of projected Drugs Produced by Fermentation Engineering sales for 2023 through 2029. With Drugs Produced by Fermentation Engineering sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs Produced by Fermentation Engineering industry.
This Insight Report provides a comprehensive analysis of the global Drugs Produced by Fermentation Engineering landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drugs Produced by Fermentation Engineering portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drugs Produced by Fermentation Engineering market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs Produced by Fermentation Engineering and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs Produced by Fermentation Engineering.
In China, 5 largest manufacturers of Fermentation Engineering for Pharmaceutical Drugs are Changchun GeneScience Pharmaceutical, 3SBio Inc, Shanghai Fosun Pharmaceutical, Sichuan Kelun Pharmaceutical and Shanghai Shyndec Pharmaceutical, which make up over 15%. Among them, Changchun GeneScience Pharmaceutical is the leader with about 6% market share. In terms of product type, Monoclonal Antibodies occupy the largest share of the total market, about 54%. And in terms of product Application, the largest application is Hospital, followed by Clinic.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs Produced by Fermentation Engineering market by product type, application, key players and key regions and countries.
Segmentation by Type:
Monoclonal Antibodies
Antibiotic
Insulin
Human Growth Hormone
Pharmaceutical Amino Acids
Others
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Monoclonal Antibodies
Antibiotic
Insulin
Human Growth Hormone
Pharmaceutical Amino Acids
Others
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Changchun GeneScience Pharmaceutical
3SBio Inc
Shanghai Fosun Pharmaceutical
Sichuan Kelun Pharmaceutical
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
United Laboratories International Holdings
Tonghua Dongbao Pharmaceutical
Joincare Pharmaceutical Group
North China Pharma
Anhui Anke Biotechnology
Gan and Lee Pharmaceuticals
Shandong Kexing Bioproducts
Harbin Pharmaceutical Group

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs Produced by Fermentation Engineering Market Size 2019-2030
2.1.2 Drugs Produced by Fermentation Engineering Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Drugs Produced by Fermentation Engineering by Country/Region, 2019, 2023 & 2030
2.2 Drugs Produced by Fermentation Engineering Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Antibiotic
2.2.3 Insulin
2.2.4 Human Growth Hormone
2.2.5 Pharmaceutical Amino Acids
2.2.6 Others
2.3 Drugs Produced by Fermentation Engineering Market Size by Type
2.3.1 Drugs Produced by Fermentation Engineering Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drugs Produced by Fermentation Engineering Market Size Market Share by Type (2019-2024)
2.4 Drugs Produced by Fermentation Engineering Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Drugs Produced by Fermentation Engineering Market Size by Application
2.5.1 Drugs Produced by Fermentation Engineering Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drugs Produced by Fermentation Engineering Market Size Market Share by Application (2019-2024)
3 Drugs Produced by Fermentation Engineering Market Size by Player
3.1 Drugs Produced by Fermentation Engineering Market Size Market Share by Player
3.1.1 Global Drugs Produced by Fermentation Engineering Revenue by Player (2019-2024)
3.1.2 Global Drugs Produced by Fermentation Engineering Revenue Market Share by Player (2019-2024)
3.2 Global Drugs Produced by Fermentation Engineering Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drugs Produced by Fermentation Engineering by Region
4.1 Drugs Produced by Fermentation Engineering Market Size by Region (2019-2024)
4.2 Global Drugs Produced by Fermentation Engineering Annual Revenue by Country/Region (2019-2024)
4.3 Americas Drugs Produced by Fermentation Engineering Market Size Growth (2019-2024)
4.4 APAC Drugs Produced by Fermentation Engineering Market Size Growth (2019-2024)
4.5 Europe Drugs Produced by Fermentation Engineering Market Size Growth (2019-2024)
4.6 Middle East & Africa Drugs Produced by Fermentation Engineering Market Size Growth (2019-2024)
5 Americas
5.1 Americas Drugs Produced by Fermentation Engineering Market Size by Country (2019-2024)
5.2 Americas Drugs Produced by Fermentation Engineering Market Size by Type (2019-2024)
5.3 Americas Drugs Produced by Fermentation Engineering Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs Produced by Fermentation Engineering Market Size by Region (2019-2024)
6.2 APAC Drugs Produced by Fermentation Engineering Market Size by Type (2019-2024)
6.3 APAC Drugs Produced by Fermentation Engineering Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drugs Produced by Fermentation Engineering Market Size by Country (2019-2024)
7.2 Europe Drugs Produced by Fermentation Engineering Market Size by Type (2019-2024)
7.3 Europe Drugs Produced by Fermentation Engineering Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs Produced by Fermentation Engineering by Region (2019-2024)
8.2 Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Type (2019-2024)
8.3 Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drugs Produced by Fermentation Engineering Market Forecast
10.1 Global Drugs Produced by Fermentation Engineering Forecast by Region (2025-2030)
10.1.1 Global Drugs Produced by Fermentation Engineering Forecast by Region (2025-2030)
10.1.2 Americas Drugs Produced by Fermentation Engineering Forecast
10.1.3 APAC Drugs Produced by Fermentation Engineering Forecast
10.1.4 Europe Drugs Produced by Fermentation Engineering Forecast
10.1.5 Middle East & Africa Drugs Produced by Fermentation Engineering Forecast
10.2 Americas Drugs Produced by Fermentation Engineering Forecast by Country (2025-2030)
10.2.1 United States Market Drugs Produced by Fermentation Engineering Forecast
10.2.2 Canada Market Drugs Produced by Fermentation Engineering Forecast
10.2.3 Mexico Market Drugs Produced by Fermentation Engineering Forecast
10.2.4 Brazil Market Drugs Produced by Fermentation Engineering Forecast
10.3 APAC Drugs Produced by Fermentation Engineering Forecast by Region (2025-2030)
10.3.1 China Drugs Produced by Fermentation Engineering Market Forecast
10.3.2 Japan Market Drugs Produced by Fermentation Engineering Forecast
10.3.3 Korea Market Drugs Produced by Fermentation Engineering Forecast
10.3.4 Southeast Asia Market Drugs Produced by Fermentation Engineering Forecast
10.3.5 India Market Drugs Produced by Fermentation Engineering Forecast
10.3.6 Australia Market Drugs Produced by Fermentation Engineering Forecast
10.4 Europe Drugs Produced by Fermentation Engineering Forecast by Country (2025-2030)
10.4.1 Germany Market Drugs Produced by Fermentation Engineering Forecast
10.4.2 France Market Drugs Produced by Fermentation Engineering Forecast
10.4.3 UK Market Drugs Produced by Fermentation Engineering Forecast
10.4.4 Italy Market Drugs Produced by Fermentation Engineering Forecast
10.4.5 Russia Market Drugs Produced by Fermentation Engineering Forecast
10.5 Middle East & Africa Drugs Produced by Fermentation Engineering Forecast by Region (2025-2030)
10.5.1 Egypt Market Drugs Produced by Fermentation Engineering Forecast
10.5.2 South Africa Market Drugs Produced by Fermentation Engineering Forecast
10.5.3 Israel Market Drugs Produced by Fermentation Engineering Forecast
10.5.4 Turkey Market Drugs Produced by Fermentation Engineering Forecast
10.6 Global Drugs Produced by Fermentation Engineering Forecast by Type (2025-2030)
10.7 Global Drugs Produced by Fermentation Engineering Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Drugs Produced by Fermentation Engineering Forecast
11 Key Players Analysis
11.1 Changchun GeneScience Pharmaceutical
11.1.1 Changchun GeneScience Pharmaceutical Company Information
11.1.2 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Product Offered
11.1.3 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Changchun GeneScience Pharmaceutical Main Business Overview
11.1.5 Changchun GeneScience Pharmaceutical Latest Developments
11.2 3SBio Inc
11.2.1 3SBio Inc Company Information
11.2.2 3SBio Inc Drugs Produced by Fermentation Engineering Product Offered
11.2.3 3SBio Inc Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 3SBio Inc Main Business Overview
11.2.5 3SBio Inc Latest Developments
11.3 Shanghai Fosun Pharmaceutical
11.3.1 Shanghai Fosun Pharmaceutical Company Information
11.3.2 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Product Offered
11.3.3 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Shanghai Fosun Pharmaceutical Main Business Overview
11.3.5 Shanghai Fosun Pharmaceutical Latest Developments
11.4 Sichuan Kelun Pharmaceutical
11.4.1 Sichuan Kelun Pharmaceutical Company Information
11.4.2 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Product Offered
11.4.3 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sichuan Kelun Pharmaceutical Main Business Overview
11.4.5 Sichuan Kelun Pharmaceutical Latest Developments
11.5 Shanghai Shyndec Pharmaceutical
11.5.1 Shanghai Shyndec Pharmaceutical Company Information
11.5.2 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Product Offered
11.5.3 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Shanghai Shyndec Pharmaceutical Main Business Overview
11.5.5 Shanghai Shyndec Pharmaceutical Latest Developments
11.6 CSPC Pharmaceutical Group
11.6.1 CSPC Pharmaceutical Group Company Information
11.6.2 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Offered
11.6.3 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 CSPC Pharmaceutical Group Main Business Overview
11.6.5 CSPC Pharmaceutical Group Latest Developments
11.7 United Laboratories International Holdings
11.7.1 United Laboratories International Holdings Company Information
11.7.2 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Product Offered
11.7.3 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 United Laboratories International Holdings Main Business Overview
11.7.5 United Laboratories International Holdings Latest Developments
11.8 Tonghua Dongbao Pharmaceutical
11.8.1 Tonghua Dongbao Pharmaceutical Company Information
11.8.2 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Product Offered
11.8.3 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Tonghua Dongbao Pharmaceutical Main Business Overview
11.8.5 Tonghua Dongbao Pharmaceutical Latest Developments
11.9 Joincare Pharmaceutical Group
11.9.1 Joincare Pharmaceutical Group Company Information
11.9.2 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Offered
11.9.3 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Joincare Pharmaceutical Group Main Business Overview
11.9.5 Joincare Pharmaceutical Group Latest Developments
11.10 North China Pharma
11.10.1 North China Pharma Company Information
11.10.2 North China Pharma Drugs Produced by Fermentation Engineering Product Offered
11.10.3 North China Pharma Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 North China Pharma Main Business Overview
11.10.5 North China Pharma Latest Developments
11.11 Anhui Anke Biotechnology
11.11.1 Anhui Anke Biotechnology Company Information
11.11.2 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Product Offered
11.11.3 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Anhui Anke Biotechnology Main Business Overview
11.11.5 Anhui Anke Biotechnology Latest Developments
11.12 Gan and Lee Pharmaceuticals
11.12.1 Gan and Lee Pharmaceuticals Company Information
11.12.2 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Product Offered
11.12.3 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Gan and Lee Pharmaceuticals Main Business Overview
11.12.5 Gan and Lee Pharmaceuticals Latest Developments
11.13 Shandong Kexing Bioproducts
11.13.1 Shandong Kexing Bioproducts Company Information
11.13.2 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Product Offered
11.13.3 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Shandong Kexing Bioproducts Main Business Overview
11.13.5 Shandong Kexing Bioproducts Latest Developments
11.14 Harbin Pharmaceutical Group
11.14.1 Harbin Pharmaceutical Group Company Information
11.14.2 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Offered
11.14.3 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Harbin Pharmaceutical Group Main Business Overview
11.14.5 Harbin Pharmaceutical Group Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂